These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 37725442)

  • 1. Autoreactive B cells in rheumatoid arthritis include mainly activated CXCR3+ memory B cells and plasmablasts.
    Reijm S; Kwekkeboom JC; Blomberg NJ; Suurmond J; van der Woude D; Toes RE; Scherer HU
    JCI Insight; 2023 Oct; 8(20):. PubMed ID: 37725442
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibodies and B cells recognising citrullinated proteins display a broad cross-reactivity towards other post-translational modifications.
    Kissel T; Reijm S; Slot LM; Cavallari M; Wortel CM; Vergroesen RD; Stoeken-Rijsbergen G; Kwekkeboom JC; Kampstra A; Levarht E; Drijfhout JW; Bang H; Bonger KM; Janssen G; van Veelen PA; Huizinga T; Scherer HU; Reth M; Toes R
    Ann Rheum Dis; 2020 Apr; 79(4):472-480. PubMed ID: 32041746
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beyond the surface - Autoreactive B cells in human autoimmune diseases.
    Scherer HU
    Semin Arthritis Rheum; 2024 Feb; 64S():152315. PubMed ID: 38008707
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Autoantibodies and the autoreactive immune response : There is more to ACPA than ACPA].
    Scherer HU
    Z Rheumatol; 2020 Nov; 79(9):893-897. PubMed ID: 32970187
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Breach of autoreactive B cell tolerance by post-translationally modified proteins.
    Dekkers JS; Verheul MK; Stoop JN; Liu B; Ioan-Facsinay A; van Veelen PA; de Ru AH; Janssen GMC; Hegen M; Rapecki S; Huizinga TWJ; Trouw LA; Toes REM
    Ann Rheum Dis; 2017 Aug; 76(8):1449-1457. PubMed ID: 28442530
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The immunologic homunculus in rheumatoid arthritis. A new viewpoint of immunopathogenesis in rheumatoid arthritis and therapeutic consequences].
    Bläss S; Engel JM; Burmester GR
    Z Rheumatol; 2001 Feb; 60(1):1-16. PubMed ID: 11263010
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autoantibodies to posttranslational modifications in rheumatoid arthritis.
    Burska AN; Hunt L; Boissinot M; Strollo R; Ryan BJ; Vital E; Nissim A; Winyard PG; Emery P; Ponchel F
    Mediators Inflamm; 2014; 2014():492873. PubMed ID: 24782594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autoantibodies and B Cells: The ABC of rheumatoid arthritis pathophysiology.
    Volkov M; van Schie KA; van der Woude D
    Immunol Rev; 2020 Mar; 294(1):148-163. PubMed ID: 31845355
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cross-reactivity of IgM anti-modified protein antibodies in rheumatoid arthritis despite limited mutational load.
    Reijm S; Kissel T; Stoeken-Rijsbergen G; Slot LM; Wortel CM; van Dooren HJ; Levarht NEW; Kampstra ASB; Derksen VFAM; Heer PO; Bang H; Drijfhout JW; Trouw LA; Huizinga TWJ; Rispens T; Scherer HU; Toes REM
    Arthritis Res Ther; 2021 Sep; 23(1):230. PubMed ID: 34479638
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathogenic, glycolytic PD-1+ B cells accumulate in the hypoxic RA joint.
    Floudas A; Neto N; Marzaioli V; Murray K; Moran B; Monaghan MG; Low C; Mullan RH; Rao N; Krishna V; Nagpal S; Veale DJ; Fearon U
    JCI Insight; 2020 Nov; 5(21):. PubMed ID: 33148884
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autoreactivity to malondialdehyde-modifications in rheumatoid arthritis is linked to disease activity and synovial pathogenesis.
    Grönwall C; Amara K; Hardt U; Krishnamurthy A; Steen J; Engström M; Sun M; Ytterberg AJ; Zubarev RA; Scheel-Toellner D; Greenberg JD; Klareskog L; Catrina AI; Malmström V; Silverman GJ
    J Autoimmun; 2017 Nov; 84():29-45. PubMed ID: 28647488
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathological role of activated mTOR in CXCR3+ memory B cells of rheumatoid arthritis.
    Iwata S; Zhang M; Hajime M; Ohkubo N; Sonomoto K; Torimoto K; Kitanaga Y; Trimova G; Todoroki Y; Miyata H; Ueno M; Nagayasu A; Kanda R; Nakano K; Nakayamada S; Sakata K; Tanaka Y
    Rheumatology (Oxford); 2021 Nov; 60(11):5452-5462. PubMed ID: 33693564
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peripheral VH4+ plasmablasts demonstrate autoreactive B cell expansion toward brain antigens in early multiple sclerosis patients.
    Rivas JR; Ireland SJ; Chkheidze R; Rounds WH; Lim J; Johnson J; Ramirez DM; Ligocki AJ; Chen D; Guzman AA; Woodhall M; Wilson PC; Meffre E; White C; Greenberg BM; Waters P; Cowell LG; Stowe AM; Monson NL
    Acta Neuropathol; 2017 Jan; 133(1):43-60. PubMed ID: 27730299
    [TBL] [Abstract][Full Text] [Related]  

  • 14. From risk to chronicity: evolution of autoreactive B cell and antibody responses in rheumatoid arthritis.
    Scherer HU; van der Woude D; Toes REM
    Nat Rev Rheumatol; 2022 Jul; 18(7):371-383. PubMed ID: 35606567
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rheumatoid factor B cell memory leads to rapid, switched antibody-forming cell responses.
    Sweet RA; Cullen JL; Shlomchik MJ
    J Immunol; 2013 Mar; 190(5):1974-81. PubMed ID: 23365079
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD21
    Thorarinsdottir K; Camponeschi A; Jonsson C; Granhagen Önnheim K; Nilsson J; Forslind K; Visentini M; Jacobsson L; Mårtensson IL; Gjertsson I
    Scand J Immunol; 2019 Aug; 90(2):e12792. PubMed ID: 31141193
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of the inherently autoreactive idiotope 9G4 on autoantibodies to citrullinated peptides and on rheumatoid factors in patients with early and established rheumatoid arthritis.
    Cambridge G; Moura RA; Santos T; Khawaja AA; Polido-Pereira J; Canhão H; Leandro MJ; Fonseca JE
    PLoS One; 2014; 9(9):e107513. PubMed ID: 25222933
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Persistently activated, proliferative memory autoreactive B cells promote inflammation in rheumatoid arthritis.
    Kristyanto H; Blomberg NJ; Slot LM; van der Voort EIH; Kerkman PF; Bakker A; Burgers LE; Ten Brinck RM; van der Helm-van Mil AHM; Spits H; Baeten DL; Huizinga TWJ; Toes REM; Scherer HU
    Sci Transl Med; 2020 Nov; 12(570):. PubMed ID: 33208502
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autoantibodies recognizing carbamylated proteins are present in sera of patients with rheumatoid arthritis and predict joint damage.
    Shi J; Knevel R; Suwannalai P; van der Linden MP; Janssen GM; van Veelen PA; Levarht NE; van der Helm-van Mil AH; Cerami A; Huizinga TW; Toes RE; Trouw LA
    Proc Natl Acad Sci U S A; 2011 Oct; 108(42):17372-7. PubMed ID: 21987802
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibody responses to de novo identified citrullinated fibrinogen peptides in rheumatoid arthritis and visualization of the corresponding B cells.
    Joshua V; Schobers L; Titcombe PJ; Israelsson L; Rönnelid J; Hansson M; Catrina AI; Pruijn GJ; Malmström V
    Arthritis Res Ther; 2016 Dec; 18(1):284. PubMed ID: 27906052
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.